Fournier Michelle-Audrey, Poirier Donald
Oncology and Molecular Endocrinology Laboratory, (Medicinal Chemistry Division), CHUQ-CHUL Research Center and Université Laval, Québec, Québec G1V 4G2, Canada.
Mol Cell Endocrinol. 2009 Mar 25;301(1-2):142-5. doi: 10.1016/j.mce.2008.08.027. Epub 2008 Sep 4.
The involvement of aromatase, steroid sulfatase (STS) and reductive 17beta-hydroxysteroid dehydrogenases (17beta-HSDs) in the production of estrogens was determined in four cell lines of endometrial cancer (Ishikawa, HEC-1A, HEC-1B and RL-95) and one cell line of cervix cancer (Hela) in culture. After incubation with 4-androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and estradiol (E2), detected suggesting that the pathway of aromatase is not important in these cell lines. In whole cells, the results show low percentages of transformation of estrone sulfate (E1S) into E1 suggesting that the entrance of E1S is difficult. However, in homogenized cells the STS activity was much higher and fully blocked by an inhibitor. Using selective inhibitors for each reductive 17beta-HSD (types 1, 5, 7 and 12), alone or in combination, we did not succeed in completely blocking the conversion of E1 into E2, suggesting that another 17beta-HSD (known or unknown) is involved in the formation of E2 from E1.
在培养的四种子宫内膜癌细胞系(石川细胞系、HEC-1A、HEC-1B和RL-95)和一种子宫颈癌细胞系(海拉细胞系)中,测定了芳香化酶、类固醇硫酸酯酶(STS)和还原型17β-羟基类固醇脱氢酶(17β-HSDs)在雌激素生成中的作用。在用4-雄烯-3,17-二酮(4-二酮)孵育后,未检测到雌激素、雌酮(E1)和雌二醇(E2),这表明芳香化酶途径在这些细胞系中并不重要。在完整细胞中,结果显示硫酸雌酮(E1S)转化为E1的比例较低,这表明E1S的进入较为困难。然而,在匀浆细胞中,STS活性要高得多,且被一种抑制剂完全阻断。使用针对每种还原型17β-HSD(1型、5型、7型和12型)的选择性抑制剂单独或联合使用,我们未能成功完全阻断E1向E2的转化,这表明另一种17β-HSD(已知或未知)参与了从E1形成E2的过程。